Dr. Charles Shapiro, director of Breast Medical Oncology at the OSUCCC – James, has been appointed to serve as chair-elect for the Survivorship Committee of the American Society of Clinical Oncology (ASCO). He will serve as chair-elect for one year, followed by a one year term as chair. He will then serve as immediate past chair.

Dr. Shapiro leads the breast cancer research program at Ohio State’s Comprehensive Cancer Center. He is a nationally known clinical investigator whose research interests include the development of novel treatments for breast cancer and treatment-related side effects of breast cancer, particularly the side effects of adjuvant chemotherapy in young women. He is currently overseeing major clinical trial and laboratory research efforts to develop new therapies that are effective for ‘triple negative’ breast cancer.

The Cancer Survivorship Committee provides leadership and oversight of ASCO’s cancer survivorship activities and assists in the implementation of the cancer survivorship components within ASCO’s mission and strategic plan. The committee reviews and assesses ASCO’s cancer survivorship portfolio and works to enhance the quality and quantity of cancer survivorship material in each program.